Approval · Notice of Compliance 3997 · 1997
LOSEC: Notice of Compliance 3997
Issued February 21, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3997
- Date
- February 21, 1997
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOSEC | 02230737 | Cancelled Post Market |
Medicinal ingredients
- OMEPRAZOLE MAGNESIUM 10 MG per TAB